VELTASSA

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug VELTASSA contains one active pharmaceutical ingredient (API):

1 Patiromer UNII 0LB9J2797D - PATIROMER SORBITEX CALCIUM

Patiromer is a non-absorbed, cation exchange polymer that contains a calcium-sorbitol complex as a counterion. Patiromer increases faecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract. Binding of potassium reduces the concentration of free potassium in the gastrointestinal lumen, resulting in a reduction of serum potassium levels. Read about Patiromer

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VELTASSA Powder for oral suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE09		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02481359, 02481367
Country: EE	Ravimiamet	Identifier(s): 1750261, 1750272, 1750283, 1750294, 1750306, 1750317, 1750328, 1750339, 1750340
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171179001, 1171179004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 113451, 578950
Country: FR	Base de données publique des médicaments	Identifier(s): 63705995
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 347345, 347347
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8313, 9061
Country: IT	Agenzia del Farmaco	Identifier(s): 045492016, 045492028, 045492030, 045492042, 045492055, 045492067, 045492079, 045492081, 045492093
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083468, 1083469, 1083470, 1083471, 1083472, 1083473, 1083474, 1083475, 1083476
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 198463, 198471
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100400251, 100400274, 100400280
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67501001, W67501002, W67501003, W67502001, W67502002, W67502003, W67503001, W67503002, W67503003
Country: US	FDA, National Drug Code	Identifier(s): 53436-084, 53436-168, 53436-252